Novitium Pharma LLC
Novitium Pharma LLC appears in FDA public data with 6 recalls, 0 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0443-2024, Class III) was initiated on March 25, 2024.
Summary
- Total Recalls
- 6
- 510(k) Clearances
- 0
- Inspections
- 5
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0443-2024 | Class III | Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pha | March 25, 2024 |
| D-0389-2024 | Class III | Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharm | March 4, 2024 |
| D-0310-2020 | Class II | Novitium Pharma Ranitidine Capsules 150 mg 60 capsules Rx Only Manufactured by: Novitium Pharma LLC | October 25, 2019 |
| D-0311-2020 | Class II | Novitium Pharma Ranitidine Capsules 150 mg 500 capsules Rx Only Manufactured by: Novitium Pharma LLC | October 25, 2019 |
| D-0312-2020 | Class II | Novitium Pharma Ranitidine Capsules 300 mg 30 capsules Rx Only Manufactured by: Novitium Pharma LLC | October 25, 2019 |
| D-0313-2020 | Class II | Novitium Pharma Ranitidine Capsules 300 mg 100 capsules Rx Only Manufactured by: Novitium Pharma LLC | October 25, 2019 |